Shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as $26.77 and last traded at $26.62, with a volume of 271863 shares trading hands. The stock had previously closed at $25.54.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on PAHC. BNP Paribas upgraded Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. Morgan Stanley set a $26.00 price objective on Phibro Animal Health and gave the company an "equal weight" rating in a report on Wednesday, June 25th. Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target on the stock in a report on Monday, June 16th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $21.80.
Get Our Latest Stock Report on PAHC
Phibro Animal Health Stock Performance
The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67. The firm has a fifty day moving average price of $23.60 and a 200 day moving average price of $22.13. The firm has a market cap of $1.13 billion, a PE ratio of 35.89, a price-to-earnings-growth ratio of 0.47 and a beta of 0.75.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. As a group, equities research analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th were issued a $0.12 dividend. The ex-dividend date of this dividend was Wednesday, June 4th. This represents a $0.48 annualized dividend and a yield of 1.71%. Phibro Animal Health's dividend payout ratio (DPR) is currently 61.54%.
Hedge Funds Weigh In On Phibro Animal Health
Several institutional investors have recently bought and sold shares of the company. Sterling Capital Management LLC grew its position in shares of Phibro Animal Health by 2.4% during the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company's stock worth $394,000 after buying an additional 448 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Phibro Animal Health by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company's stock worth $260,000 after buying an additional 546 shares in the last quarter. Algert Global LLC grew its position in shares of Phibro Animal Health by 1.4% during the first quarter. Algert Global LLC now owns 97,612 shares of the company's stock worth $2,085,000 after buying an additional 1,340 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Phibro Animal Health during the fourth quarter worth about $29,000. Finally, National Bank of Canada FI acquired a new position in shares of Phibro Animal Health during the first quarter worth about $30,000. 99.34% of the stock is owned by institutional investors and hedge funds.
Phibro Animal Health Company Profile
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
